進階傷口治療：全球市場展望 2011-2021

進階傷口治療：全球市場展望 2011-2021 是由出版商Visiongain在2011年11月所出版的。 這份英文市場調查報告書包含157 Pages 價格從美金2642起跳。

簡介

本報告為，關注美國、日本、德國、法國、義大利、西班牙、英國、中國、印度等先進國家未來將快速成長之進階傷口治療（AWC：Advanced Wound Care）市場，並匯整2021年間銷售及收益規模預測、新技術崛起、治療方式及藥劑開發具體趨勢、今後市場發展機會、挑戰等最新調查資訊及分析，以下列摘要形式闡述。

第1章 實施概要

• 進階傷口治療：市場驗證
• 各章概要
• 調查、分析方式
• 進階傷口治療用語集

第2章 簡介

• 傷口定義？
  • 傷口分類
• 皮膚
  • 傷口護理階段
• 傷口護理
  • 傷口護理之功能
  • 傷口護理之歷史
• 傷口護理類別
  • 傳統傷口護理
  • 進階傷口治療（AWC）
• 進階傷口規範
  • 美國及許可、法規系統
  • 地區市場分析 2010

第3章 全球進階傷口治療市場概要 2010-2021

• 進階傷口治療：市場概要
• 地區市場分析 2010
• 全球進階傷口治療市場預測 2010-2015
• 全球進階傷口治療市場預測 2016-2021
• 主要國家之進階傷口治療市場：銷售預測 2011-2021
• 美國、歐洲、日本市場 2011-2021
• 中國、印度市場 2011-2021

第4章 濕潤傷口護理市場 2010-2021

• 濕潤傷口護理市場：概要
• 濕潤傷口護理市場區隔 2011-2021
• 濕潤傷口護理開發產品線 2011
• 濕潤傷口護理市場之SWOT分析 2011-2021

第5章 傷口護理設備市場 2010-2021

• 傷口護理設備市場：概要
• 負壓傷口治療（NPWT：Negative Pressure Wound Therapy）市場
• 負壓傷口治療市場預測 2011-2015
• 負壓傷口治療市場預測 2015-2021
• 傷口護理設備開發產品線
• 傷口護理設備市場之SWOT分析 2011-2021

第6章 傷口護理之生物製劑市場 2010-2021

• 傷口護理之生物製劑市場：概要
• 2010年皮膚替代市場
• 膠原蛋白類治療
• 細胞治療市場
• 生物製劑開發產品線
• 傷口護理生物製劑市場之SWOT分析 2010-2021

第7章 進階傷口治療市場：企業別分析 2010

• Smith & Nephew（S&N）
• Kinetic Concepts Inc（KCI）
• ConvaTec
• Coloplast
• Systagenix Wound Management

第8章 專家看法

• Ingenious Technologies Corporation創始人・CEO、Dr Edward Lin
• University of Central Florida、Burnett School of Biomedical Science、神經科學教授、Kiminobu Sugaya

第9章 結論

• 進階傷口治療市場 2010-2021
  • 慢性傷口增加為其成長驅力
  • 新興市場帶動成長
• 濕潤傷口護理市場
• 傷口護理設備市場
• 傷口護理之生物製劑市場

附錄

圖表一覽

企業索引

目錄

Abstract

Report Details

The wound care devices and biologics segment within the advanced wound care market are set for rapid growth over the next ten years. The growth in the market will be driven primarily by the increasing prevalence of diabetes and obesity, coupled with the aging population, which will increase the incidence of chronic wounds. The adoption of expensive but more effective wound care devices and biologics will increase in the developed countries in the near future. Visiongain calculates the total advanced wound care market to be worth $6.7bn in 2011.

Our latest pharma report - Advanced Wound Care: World Market Prospects, 2011-2021 - examines the global advanced wound care market over the next decade, providing detailed market forecasts for three main segments of the market. The report analyses recent trends in this market and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report offers in-depth analysis of the opportunities and challenges facing companies in the market throughout the world. The various drivers and restraints of the market are evaluated in order to provide readers with specific insights into the future direction of the industry, while the analysis is underpinned by original interviews with experts within the advanced wound care market.

The Advanced Wound Care: World Market Prospects, 2011-2021 examines the moist wound care, wound care devices and wound care biologics market with respect to the market size, leading companies and products, and promising products in the pipeline. Visiongain predicts that this market will grow steadily to 2021, primarily driven by a rise in the prevalence of chronic wounds including diabetic ulcers and pressure ulcers, approval of innovative devices, and increased patient adoption of existing and newly-marketed products.

How will the advanced wound care market develop this decade? Which regions offer the most significant growth opportunities between 2011 and 2021? Which of the advanced wound care submarkets are growing most strongly? Who are the leading companies in the advanced wound care market? What are the most promising products in development and when are they expected to receive market approval? Visiongain answers these critical questions and many more through the in-depth analyses that are presented in this report.

Detailed analysis of the global Advanced Wound Care Market

Advanced Wound Care: World Market Prospects, 2011-2021 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. This report provides detailed sales forecasts, market share analyses, discussions of pipeline developments and analyses of commercial drivers and restraints, including SWOT analysis. There are 114 tables and figures included, as well as two full interviews with relevant authorities. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work.

Why you should buy Advanced Wound Care: World Market Prospects, 2011-2021

In this report, you will receive the following benefits in particular:

• You will receive our assessment of the current market for advanced wound care, with respect to the leading segments, products, companies and national markets
• You will discover sales trends for the overall advanced wound care market from 2011 to 2021 - seeing where commercial growth will occur
• You will discover sales trends for the main segments - moist wound care, wound care devices, and wound care biologics - from 2011 to 2021, with detailed discussions of market potential
• You will receive sales forecasts for leading geographical markets (US, Japan, Germany, France, Italy, Spain, UK, China and India), with informed discussion
• You will assess leading companies in the advanced wound care market along with their marketed and pipeline products
• You will receive our analyses of the future of advanced wound care market, including assessment of some products in the R&D pipeline
• You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the advanced wound care segment from 2011 onwards
• You will be able to investigate competition and opportunities influencing the advanced wound care market from 2011 onwards
• You will see what will stimulate and restrain the advanced wound care market from 2011
• You will discover the unmet needs in the market, driving the growth from 2011 onwards
• You will view expert opinion from our survey, including full interview transcripts.

Table of Contents

1. Executive Summary

• 1.1 Advanced Wound Care: Market Review
• 1.2 Overview of Chapter Content
• 1.3 Research and Analysis Method
• 1.4 Glossary of Terms Relating to Advanced Wound Care

2. Introduction

• 2.1 What is a Wound?
  • 2.1.1 Wound Classification
    • 2.1.1.1 Acute Wounds
    • 2.1.1.2 Chronic Wounds
      • 2.1.1.2.1 The Increasing Prevalence of Chronic Wounds
    • 2.1.1.3 Burns
• 2.2 The Skin
  • 2.2.1 The Phases of Wound Healing
    • 2.2.1.1 The Inflammatory Phase
    • 2.2.1.2 The Proliferation Phase
    • 2.2.1.3 The Fibroblastic Phase
    • 2.2.1.4 The Maturation Phase
• 2.3 Wound Care
  • 2.3.1 The Functions of Wound Care
  • 2.3.2 The History of Wound Care
• 2.4 Wound Care Categories
  • 2.4.1 Traditional Wound Care
  • 2.4.2 Advanced Wound Care (AWC)
    • 2.4.2.1 Moist Wound Care (MWC)
      • 2.4.2.1.1 Alginate Dressings
      • 2.4.2.1.2 Foam Dressings
      • 2.4.2.1.3 Hydrocolloid Dressings
      • 2.4.2.1.4 Hydrogel Dressings
    • 2.4.2.2 Wound Care Devices
      • 2.4.2.2.1 Negative Pressure Wound Therapy (NPWT)
      • 2.4.2.2.2 Ultrasound for Wound Therapy
      • 2.4.2.2.3 Electrical Stimulation
    • 2.4.2.3 Biologics
      • 2.4.2.3.1 Skin Replacement Therapies
      • 2.4.2.3.2 Collagen Based Therapies
      • 2.4.2.3.3 Cell Therapies
• 2.5 Regulation of Advanced Wound Care
  • 2.5.1 The US Approval and Regulation System
  • 2.5.2 The European Approval and Regulation Process

3. The Global Advanced Wound Care Market, 2010-2021

• 3.1 Advanced Wound Care: Market Overview
  • 3.1.1 The Size of the Advanced Wound Care Market in 2010
• 3.2 Regional Market Breakdown, 2010
  • 3.2.1 The US, European and Japanese Markets, 2010
  • 3.2.2 The Chinese and Indian Market, 2010
• 3.3 Global Advanced Wound Care Market Forecast, 2011-2015
• 3.4 Global Advanced Wound Care Market Forecast, 2015-2021
• 3.5 Leading National Markets for Advanced Wound Care: Sales Forecasts, 2011-2021
• 3.5.1 The US, European and Japanese Markets, 2011-2021
  • 3.5.1.1 The US Market
  • 3.5.1.2 The European Market
  • 3.5.1.3 The Japanese Market
• 3.5.2 The Chinese and Indian Markets, 2011-2021
  • 3.5.2.1 The Chinese Market
  • 3.5.2.2 The Indian Market

4. The Moist Wound Care Market, 2010-2021

• 4.1 The Moist Wound Care Market: Overview
  • 4.1.1 The Moist Wound Care Market, 2010
  • 4.1.2 Moist Wound Care Market Forecast, 2011-2021
• 4.2 The Moist Wound Care Market Segments, 2011-2021
  • 4.2.1 The Hydrocolloid Dressings Market
  • 4.2.2 The Foam Dressings Market
  • 4.2.3 The Alginate Dressings Market
  • 4.2.4 The Hydrogel Dressings Market
  • 4.2.5 Other MWC Dressings Market
    • 4.2.5.1 Hydrofiber Technology (ConvaTec)
• 4.3 The Moist Wound Care Pipeline
  • 4.3.1 NanoDOX (Nanotherapeutics)
  • 4.3.2 Novel Antimicrobial Silver Dressing (AGT Sciences Ltd)
  • 4.3.3 '1' Primary Wound Dressing (Phytoceuticals)
• 4.4 SWOT Analysis of the Moist Wound Care Market, 2011-2021
  • 4.4.1 Strengths
    • 4.4.1.1 Established Segment of the Market
    • 4.4.1.2 Wide Variety of Products
    • 4.4.1.3 More Effective than Traditional Wound Care
  • 4.4.2 Weaknesses
    • 4.4.2.1 Less Effective than Some Devices and Biologics
    • 4.4.2.2 Weak R&D Pipeline
  • 4.4.3 Opportunities
    • 4.4.3.1 Increasing Prevalence of Chronic Wounds
    • 4.4.3.2 Cheap Alternative to Devices and Biologics
  • 4.4.4 Threats
    • 4.4.4.1 Emerging Technologies May be More Effective
    • 4.4.4.2 Lack of R&D Spending Will Stifle Innovation

5. Wound Care Devices Market, 2010-2021

• 5.1 Wound Care Devices Market: Overview
  • 5.1.1 The Wound Care Devices Market in 2010: Segment and Regional Breakdown
  • 5.1.2 The Wound Care Devices Forecast, 2011-2021
• 5.2 The NPWT Market
  • 5.2.1 The NPWT Market in 2010
  • 5.2.2 Leading NPWT Devices: Product Analysis
    • 5.2.2.1 V.A.C. Therapy (KCI)
      • 5.2.2.1.1 V.A.C. Via (Kinetic Concepts Inc)
    • 5.2.2.2 RENASYS Systems (Smith & Nephew)
    • 5.2.2.3 Other NPWT Systems
      • 5.2.2.3.1 POSiFECT (Biofisica)
• 5.3 The NPWT Market Forecast, 2011-2015
• 5.4 The NPWT Market Forecast, 2015-2021
• 5.5 The Wound Care Devices Pipeline
  • 5.5.1 dermaPACE (Sanuwave Health)
  • 5.5.2 O-ACE-Sys (Ingenious Technologies Corporation)
  • 5.5.3 Red Light Wave Therapy (Lightwave Technologies)
  • 5.5.4 MIST Therapy (Celleration)
• 5.6 SWOT Analysis of the Wound Care Devices Market, 2011-2021
  • 5.6.1 Strengths
    • 5.6.1.1 More Effective than Other Forms of Wound Care
    • 5.6.1.2 Constant Innovation in the Market
  • 5.6.2 Weaknesses
    • 5.6.2.1 Dominated by Few Large Companies
    • 5.6.2.2 NPWT Dominates the Market
  • 5.6.3 Opportunities
    • 5.6.3.1 Low Cost NPWT Systems will Drive Growth
    • 5.6.3.2 Increasing Prevalence of Chronic Wounds
  • 5.6.4 Threats
    • 5.6.4.1 Controversy Regarding Safety of NPWT
    • 5.6.4.2 Ongoing Legal Battles Threaten Innovation

6. The Wound Care Biologics Market, 2010-2021

• 6.1 Wound Care Biologics Market: Overview
  • 6.1.1 Wound Care Biologics Market in 2010: Market Segments and Regional Breakdown
  • 6.1.2 The Wound Care Biologics Market Forecast, 2011-2021
• 6.2 The Skin Replacement Market
  • 6.2.1 The Skin Replacement Market in 2010
  • 6.2.2 Leading Products in the Skin Replacement Market, 2010
    • 6.2.2.1 Dermagraft (Advanced BioHealing, a Division of Shire Pharmaceuticals)
    • 6.2.2.2 Apligraf (Organogenesis)
    • 6.2.2.3 Other Leading Products
  • 6.2.3 The Skin Replacement Market Forecast, 2011-2015
  • 6.2.4 The Skin Replacement Market Forecast, 2015-2021
• 6.3 Collagen Based Therapy
  • 6.3.1 Collagen Based Therapy Market in 2010
  • 6.3.2 The Collagen Based Therapy Market Forecast, 2011-2015
  • 6.3.3 The Collagen Based Therapy Market Forecast, 2015-2021
• 6.4 The Cell Therapy Market
  • 6.4.1 The Cell Therapy Market in 2010
  • 6.4.2 Leading Products in the Cell Therapy Market, 2010
  • 6.4.3 The Cell Therapy Market Forecast, 2011-2015
• 6.4.4 The Cell Therapy Market Forecast, 2015-2021
• 6.5 The Biologics Pipeline
  • 6.5.1 Stem Cells
    • 6.5.1.1 Stem Cell Skin Gun (McGowan Institute for Regenerative Medicine at the University of Pittsburgh)
    • 6.5.1.2 Adult Stem Cells (Cryo-Cell International and The Snyder Wound Research Institute)
    • 6.5.1.3 Mesenchymal Stem Cells (Nara University, Japan)
  • 6.5.2 Artificial Skin
    • 6.5.2.1 e-Skin (UC Berkeley)
    • 6.5.2.2 Genetically Modified Artificial Skin (University of Cincinnati)
  • 6.5.3 Cell Therapy
    • 6.5.3.1 ReCell (Avita Medical)
  • 6.5.4 Automated Artificial Skin Production
    • 6.5.4.1 The Tissue Factory (Fraunhofer Institute)
  • 6.5.5 Nanotechnology
    • 6.5.5.1 DermaFuse (Missouri S&T and Mo-Sci Corporation)
    • 6.5.5.2 Phytochemical Tissue Bonding (Harvard University Institute of Photomedicine)
    • 6.5.5.3 Giant Unilamellar Vesicles (University of Bath)
  • 6.5.6 Collagen Based Therapy
    • 6.5.6.1 Artificial Collagen Based Wound Care (Cornell University)
  • 6.5.7 Diagnostic Tests
    • 6.5.7.1 WOUNDCHEK (Systagenix Wound Management)
• 6.6 SWOT Analysis of the Wound Care Biologics Market, 2011-2021
  • 6.6.1 Strengths
    • 6.6.1.1 More Effective Than Other Forms of Wound Care
    • 6.6.1.2 New Technology with Constant Innovation
    • 6.6.1.3 Strong R&D Pipeline
  • 6.6.2 Weaknesses
    • 6.6.2.1 Small Start-up Companies Dominate the Market
    • 6.6.2.2 Expensive Technology
    • 6.6.2.3 High Barriers to Entry
  • 6.6.3 Opportunities
    • 6.6.3.1 Strong Innovation Will Drive Growth
    • 6.6.3.2 Stem Cells Offer Multiple Opportunities
    • 6.6.3.3 Increasing Prevalence of Chronic Wounds
  • 6.6.4 Threats
    • 6.6.4.1 Controversy Regarding the Effectiveness of Some Biologics
    • 6.6.4.2 High Barriers to Entry will Deter Competitors
    • 6.6.4.3 Competition from MWC and Devices

7. Advanced Wound Care Market: Analysis by Company, 2010

• 7.1 Smith & Nephew (S&N)
  • 7.1.1 Smith & Nephew Advanced Wound Care Sales, 2010
  • 7.1.2 Smith & Nephew Pipeline
• 7.2 Kinetic Concepts Inc (KCI)
  • 7.2.1 KCI Advanced Wound Care Sales, 2010
  • 7.2.2 KCI Pipeline
  • 7.2.3 The Sale of KCI
• 7.3 ConvaTec
  • 7.3.1 ConvaTec Sales, 2010
  • 7.3.2 ConvaTec Advanced Wound Care Sales, 2010
  • 7.3.3 ConvaTec Pipeline
• 7.4 Coloplast
  • 7.4.1 Coloplast Sales, 2010
  • 7.4.2 Coloplast Advanced Wound Care Sales, 2009/2010
• 7.5 Systagenix Wound Management
  • 7.5.1 Systagenix Pipeline

8. Expert Opinions

• 8.1 Dr Edward Lin, CEO & Founder of Ingenious Technologies Corporation
  • 8.1.1 The Wound Care Market
  • 8.1.2 O-ACE-Sys Device Being Developed by Dr Lin
  • 8.1.3 NPWT Devices
  • 8.1.4 The Future of Wound Care Devices
• 8.2 Professor Kiminobu Sugaya, Professor of Neuroscience, Burnett School of Biomedical Science, University of Central Florida
  • 8.2.1 The Current Stem Cell Field
  • 8.2.2 Public Perception of Stem Cell Research
  • 8.2.3 iPS cells and Wound Healing

9. Conclusions

• 9.1 The Advanced Wound Care Market, 2010-2021
  • 9.1.1 Growth will be Driven by an Increasing Prevalence of Chronic Wounds
  • 9.1.2 Emerging Markets will Drive Growth
• 9.2 The Moist Wound Care Market
• 9.3 The Wound Care Devices Market
• 9.4 The Wound Care Biologics Market

Appendix A

Appendix B - Visiongain report evaluation form

List of Tables

• Table 2.1 The Rules of Nine: Percentage (%) of Total Body Classification System
• Table 2.2 The Classification of Burns by Depth: Degree Classification System
• Table 2.3 The Classification of Burns by Severity
• Table 2.4 The Wound Care Market ($bn) by Sectors, 2010
• Table 2.5 The Advantages and Disadvantages of Moist Wound Care
• Table 2.6 The Benefits and Risks of Skin Grafting
• Table 3.1 The Advanced Wound Care Market ($bn) by Segments, 2010
• Table 3.2 Leading National Markets for Advanced Wound Care ($bn), 2010
• Table 3.3 Global Advanced Wound Care Market Forecast ($bn), 2010-2015
• Table 3.4 Global Advanced Wound Care Market Forecast ($bn), 2015-2021
• Table 3.5 Leading Advanced Wound Care National Market Forecasts ($bn), 2010-2015
• Table 3.6 Leading Advanced Wound Care National Market Forecasts ($bn), 2015-2021
• Table 3.7 Chinese Advanced Wound Care Market: Drivers and Restraints, 2011-2021
• Table 4.1 The Moist Wound Care Market ($bn) by Segments, 2010
• Table 4.2 The Moist Wound Care Market ($bn) by Country/Region, 2010
• Table 4.3 The Moist Wound Care Market Forecast ($bn), 2010-2015
• Table 4.4 The Moist Wound Care Market Forecast ($bn), 2015-2021
• Table 4.5 Moist Wound Care Products Pipeline, 2011
• Table 4.6 SWOT Analysis of the Moist Wound Care Market, 2011-2021
• Table 5.1 The Wound Care Device Market ($bn) by Segments, 2010
• Table 5.2 The Wound Care Devices Market ($bn) by Country/Region, 2010
• Table 5.3 The Wound Care Devices Market Forecast ($bn), 2010-2015
• Table 5.4 The Wound Care Devices Market Forecast ($bn), 2015-2021
• Table 5.5 Leading Products in the NPWT Market: Sales ($bn) and Market Share (%), 2010
• Table 5.6 The NPWT Market Forecast ($bn), 2010-2015
• Table 5.7 The NPWT Market Forecast ($bn), 2015-2021
• Table 5.8 Drivers and Restraints in the NPWT Market, 2010-2021
• Table 5.9 Wound Care Devices Development Pipeline, 2011
• Table 5.10 SWOT Analysis of the Wound Care Devices Market, 2011-2021
• Table 6.1 The Wound Care Biologics Market ($m) by Segments, 2010
• Table 6.2 The Wound Care Biologics Market ($m) by Country/Region, 2010
• Table 6.3 The Wound Care Biologics Market Forecast ($bn), 2010-2015
• Table 6.4 The Wound Care Biologics Market Forecast ($bn), 2015-2021
• Table 6.5 Drivers and Restraints in the Biologics Market, 2011-2021
• Table 6.6 Dermagraft Sales ($m) 2007-2010
• Table 6.7 Other Leading Products in the Skin Replacement Market, 2010
• Table 6.8 The Skin Replacement Market Forecast ($bn), 2010-2015
• Table 6.9 The Skin Replacement Market Forecast ($bn), 2015-2021
• Table 6.10 Leading Products in the Collagen Based Therapy Market, 2010
• Table 6.11 The Collagen Based Therapy Market Forecast ($bn), 2010-2015
• Table 6.12 The Collagen Based Therapy Market Forecast ($bn), 2015-2021
• Table 6.13 Leading Products in the Cell Therapy Market, 2010
• Table 6.14 The Cell Therapy Market Forecast ($m), 2010-2015
• Table 6.15 The Cell Therapy Market Forecast ($m), 2015-2021
• Table 6.16 The Wound Care Biologics Development Pipeline, 2011
• Table 6.17 SWOT Analysis of the Wound Care Biologics Market, 2011-2021
• Table 7.1 Smith & Nephew Sales ($m) by Business Segments, 2010
• Table 7.2 Smith & Nephew Sales ($m) by Region, 2010
• Table 7.3 Smith & Nephew Advanced Wound Management Sales ($m) by Region, 2010
• Table 7.4 KCI Total Revenue ($m) by Sales and Rentals, 2010
• Table 7.5 KCI Total Sales ($m) by Business Segments, 2010
• Table 7.6 KCI Active Healing Solutions (AHS) Sales ($m) by Region, 2010
• Table 7.7 ConvaTec Sales ($m) by Business Segments, 2010
• Table 7.8 ConvaTec Sales ($m) by Region, 2010
• Table 7.9 Coloplast Sales ($bn) by Business Segments, 2009/2010
• Table 7.10 Coloplast Sales ($bn) by Region, 2009/2010
• Table 9.1 Global Advanced Wound Care Market: Drivers and Restraints, 2011-2021

List of Figures

• Figure 2.1 The Phases of Wound Healing and Duration (Days)
• Figure 2.2 Market Shares (%) of the Leading Sectors in the Wound Care Market, 2010
• Figure 3.1 The Advanced Wound Care Market Share (%) by Segments, 2010
• Figure 3.2 The Advanced Wound Care Market ($bn) by Segments, 2010
• Figure 3.3 The Advanced Wound Care Market Share (%) in Leading National Markets, 2010
• Figure 3.4 The Advanced Wound Care Market ($bn) in Leading National Markets, 2010
• Figure 3.5 Global Advanced Wound Care Market Forecast ($bn), 2010-2015
• Figure 3.6 Global Advanced Wound Care Market Forecast ($bn), 2015-2021
• Figure 3.7 The US Advanced Wound Care Market Forecast ($bn), 2010-2015
• Figure 3.8 The European Advanced Wound Care Market Forecast ($bn), 2010-2015
• Figure 3.9 The Asian Advanced Wound Care Market Forecasts ($bn), 2010-2015
• Figure 3.10 The US Advanced Wound Care Market Forecast ($bn), 2015-2021
• Figure 3.11 The European Advanced Wound Care Market Forecast ($bn), 2015-2021
• Figure 3.12 The Asian Advanced Wound Care Market Forecasts ($bn), 2015-2021
• Figure 4.1 The Moist Wound Care Market Share (%) by Segments, 2010
• Figure 4.2 The Moist Wound Care Market ($bn) by Segments, 2010
• Figure 4.3 Moist Wound Care Market Shares (%) by Country/Region, 2010
• Figure 4.4 Total Moist Wound Care Market Forecast ($bn), 2010-2015
• Figure 4.5 Total Moist Wound Care Market Forecast ($bn), 2015-2021
• Figure 5.1 The Wound Care Devices Market Share (%) by Segments, 2010
• Figure 5.2 The Wound Care Devices Market ($bn) by Segments, 2010
• Figure 5.3 The Wound Care Devices Market Share (%) by Country/Region, 2010
• Figure 5.4 The Wound Care Devices Market Sales ($bn) by Country/Region, 2010
• Figure 5.5 Total Wound Care Devices Market Forecast ($bn), 2010-2015
• Figure 5.6 NPWT and Ultrasound Wound Therapy Devices Market Forecasts ($bn), 2010-2015
• Figure 5.7 Total Wound Care Devices Market Forecast ($bn), 2015-2021
• Figure 5.8 NPWT and Ultrasound Wound Therapy Devices Market Forecasts ($bn), 2015-2021
• Figure 5.9 The NPWT Devices Market Share (%) by Leading Products, 2010
• Figure 5.10 The NPWT Market Forecast ($bn), 2010-2015
• Figure 5.11 The NPWT Market Forecast ($bn), 2015-2021
• Figure 6.1 The Wound Care Biologics Market Share (%) by Segments, 2010
• Figure 6.2 The Wound Care Biologics Market ($m) by Segments, 2010
• Figure 6.3 The Wound Care Biologics Market Share (%) by Country/Region, 2010
• Figure 6.4 The Wound Care Biologics Market Sales ($m) by Country/Region, 2010
• Figure 6.5 The Biologics Market Forecast ($bn), 2010-2021
• Figure 6.6 Dermagraft Sales ($m) 2007-2010
• Figure 6.7 The Skin Replacement Market Forecast ($bn), 2010-2015
• Figure 6.8 The Skin Replacement Market Forecast ($bn), 2015-2021
• Figure 6.9 The Collagen Based Therapy Market Forecast ($bn), 2010-2015
• Figure 6.10 The Collagen Based Therapy Market Forecast ($bn), 2015-2021
• Figure 6.11 The Cell Therapy Market Forecast ($m), 2010-2015
• Figure 6.12 The Cell Therapy Market Forecast ($bn), 2015-2021
• Figure 7.1 Smith & Nephew Sales Share (%) by Business Segment, 2010
• Figure 7.2 Smith & Nephew Sales ($m) by Business Segment, 2010
• Figure 7.3 Smith & Nephew Sales Share (%) by Region, 2010
• Figure 7.4 Smith & Nephew Sales ($m) by Region, 2010
• Figure 7.5 Smith & Nephew Advanced Wound Management Sales Share (%) by Region, 2010
• Figure 7.6 KCI Total Revenue Shares (%) by Sales and Rentals, 2010
• Figure 7.7 KCI Total Sales Share (%) by Business Segments, 2010
• Figure 7.8 KCI Total Sales ($m) by Business Segments, 2010
• Figure 7.9 KCI Active Healing Solutions (AHS) Sales Share (%) by Region, 2010
• Figure 7.10 ConvaTec Sales Share (%) by Business Segment, 2010
• Figure 7.11 ConvaTec Sales ($m) by Business Segment, 2010
• Figure 7.12 ConvaTec Sales Share (%) by Region, 2010
• Figure 7.13 Coloplast Sales Share (%) by Business Segments, 2009/2010
• Figure 7.14 Coloplast Sales ($bn) by Business Segments, 2009/2010
• Figure 7.15 Coloplast Sales Share (%) by Region, 2009/2010

Companies Listed

• 3M
• ACell
• Advanced BioHealing
• Advanced Medical Solutions Group
• AGT Sciences Ltd
• Apax Partners
• Avista Capital partners
• Avita Medical
• Biofisica
• Biolight AB
• Blackstone Group
• BlueSky Medical
• Boehringer Wound Systems LLC
• Brennen Medical
• Bristol-Myers Squibb
• Celleration
• Center for Biologics Evaluation and Research
• Centres for Medicare & Medicaid Services (CMS)
• ConvaTec
• Cornell University
• Covidien
• Cryo-Cell International
• Derma Sciences
• Dr. Suwelack Skin & Health Care
• E.R Squibb & Sons
• Fidia
• Genadyne Biotechnologies
• Genzyme
• Genzyme Biosurgery
• Food & Drug Administration (FDA)
• Forticell Bioscience
• Harvard University Institute of Photomedicine
• HealO Medical
• HealthPoint
• Ingenious Technologies Corporation
• Innovative Therapies Inc
• Integra Life Sciences
• Japanese Ministry of Health, Labour and Welfare (MHLW)
• Johnson & Johnson
• Kalypto Medical
• Kinetic Concepts Inc (KCI)
• Lescarden
• LifeCell
• Lightwave Technologies
• MacroCure
• Massachusetts Institute of Technology (MIT)
• McGowan Institute for Regenerative Medicine at the University of Pittsburgh
• MCS Med
• Medela Inc
• Medestea Internazionale
• Medline Industries
• Missouri S&T
• Mo-Sci Corporation
• Molnlycke
• Nanotherapeutics
• Nara University, Japan
• Nordic Capital Partners
• Novartis
• Office of Combination Products
• Ogenix Corporation
• One Equity Partners
• Ortec International
• Osiris Therapeutics
• Pfizer
• Phytoceuticals
• Polyheal
• Progenicyte
• Prospera
• Sanuwave Health Inc
• Smith & Nephew
• Snyder Wound Research Institute
• Spiracur
• Systagenix
• Talley Group
• The Fraunhofer Institute for Interfacial Engineering and Biotechnology
• UC Berkeley
• UDL Laboratories
• UK Healthcare Industry Task Force
• University Hospital Bern, Switzerland
• University of Bath
• University of Chicago
• University of Cincinnati
• US Armed Forces Institute of Regenerative Medicine
• Wound Management Technologies
• Wright Medical

Press Release

全球先進創傷治療市場は、2021年將達到146億美元規模

相關商品

傷口護理相關市場調查報告書

全球先進型創傷管理市場:開發平台分析，競爭環境，到2018年為止的市場預測
Advanced Wound Management - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
價格 : US $ 3995
出版日期 : 2012年04月

加拿大的傷口敷料市場趨勢:分析及預測
Canada Wound Dressings Market Trends Until 2018
價格 : US $ 2000
出版日期 : 2012年04月

美國的傷口敷料市場趨勢:分析及預測
US Wound Dressings Market Trends Until 2018
價格 : US $ 2000
出版日期 : 2012年04月

Visiongain發行的醫療設備相關市場調查報告書

磁振造影(核磁共振攝影)診斷設備:全球市場預測 2012-2022年

Magnetic Resonance Imaging (MRI) Systems: Global Market Outlook 2012-2022

價格 : US $ 2642

出版日期 : 2012年03月

生物性骨材:全球市場展望 2012-2022年

Orthobiologics: Global Market Prospects 2012-2022

價格 : US $ 2642

出版日期 : 2012年03月

輸液幫浦:技術及市場:2012-2022年

Infusion Pumps: Technology and Market 2012-2022

價格 : US $ 2642

出版日期 : 2012年02月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!